Last updated on March 2019

ABI-009 an mTOR Inhibitor for Patients With Severe Pulmonary Arterial Hypertension

Brief description of study

mTOR activation has been shown to be relevant in the development and progression of pulmonary hypertension. Inhibition of mTOR has been shown to reverse or regress pulmonary hypertension in animal models. ABI-009 is an albumin-bound mTOR inhibitor with improved penetration in lung tissue.

Clinical Study Identifier: NCT02587325

Find a site near you

Start Over

Inova Fairfax Hospital

Falls Church, VA United States
  Connect »